ELISpot Flex: Mouse IgA (ALP) 3865-2A from Mabtech AB | Biocompare.com

Supplier Images

ELISpot Flex: Mouse IgA (ALP)

Be the first to write a review!

Citations:

Supplier Page from
Mabtech AB for
ELISpot Flex: Mouse IgA (ALP)

Description

Mouse IgA ELISpot Flex enables enumeration of B cells secreting total mouse IgA as well as antigen-specific mouse IgA. It contains matched quantities of monoclonal capture and detection antibodies, Streptavidin-ALP and polyclonal activators

Product Specs
ItemELISpot Flex: Mouse IgA (ALP)
CompanyMabtech AB
Price Pricing Info Supplier Page View Company Product Page
Catalog Number3865-2A
Quantityfor 4 plate
ApplicationsELISpot
Reactivitymouse
Detection TargetIgA
Conjugate/Tag/LabelALP
NCBI Full Gene Nameimmunoglobulin heavy constant alpha
NCBI Gene AliasesIgA, Igh-2
TypeStreptavidin-ALP
Formatwithout plates
ComponentsCapture mAb (MT45A),Biotinylated detection mAb (MT39A),Streptavidin-ALP,R848,Recombinant mouse IL-2

Add to Compare List

Mabtech AB

Mabtech AB

Box 1233

Nacka Strand, SE-131 28

Sweden

Phone: +46 8 716 27 00
+46 8 716 27 01

Company Profile

Website: http://www.mabtech.com

(1) Nod2 is required for antigen-specific humoral responses against antigens orally delivered using a recombinant Lactobacillus vaccine platformPloS oneJanuary 1, 2018Bumgardner SA, Zhang L, LaVoy AS, Andre B, Frank CB, Kajikawa A, Klaenhammer TR, Dean GA.

(2) Vaccine-induced Th17 cells are established as resident memory cells in the lung and promote local IgA responsesMucosal immunologyJanuary 1, 2017Christensen D, Mortensen R, Rosenkrands I, Dietrich J, Andersen P.

(3) PLGA-microencapsulation protects Salmonella typhi outer membrane proteins from acidic degradation and increases their mucosal immunogenicityVaccineJuly 29, 2016Carreño JM, Perez-Shibayama C, Gil-Cruz C, Printz A, Pastelin R, Isibasi A, Chariatte D, Tanoue Y, Lopez-Macias C, Gander B, et al.

(4) Secretory IgA as a vaccine carrier for delivery of HIV antigen to M cellsEuropean journal of immunologyMarch 1, 2015Rochereau N, Pavot V, Verrier B, Ensinas A, Genin C, Corthésy B, Paul S.

(5) M cell-targeting strategy facilitates mucosal immune response and enhances protection against CVB3-induced viral myocarditis elicited by chitosan-DNA vaccineVaccineJuly 31, 2014Ye T, Yue Y, Fan X, Dong C, Xu W, Xiong S.

Be the First to Write a Review!